Although PON1 activity did not differ significantly between the three groups (borderline significance), MASLD + T2D patients exhibited significantly lower PON1 activity compared to the CG.
← all excerpts
Transcriptomic, Redox Status and Adipocytokine Profiles in Metabolic Dysfunction-Associated Steatotic Liver Disease: Impact of Coexisting Type 2 Diabetes.
2
—
—
The sentences
Although the overall group difference for PON1 did not reach statistical significance, post hoc analysis revealed significantly lower PON1 activity in the MASLD + T2D group compared to the CG ( Table 2 ).